How to Reconstitute Cerebrolysin

Why Cerebrolysin Needs No Reconstitution

Unlike many peptide therapeutics supplied as lyophilized (freeze-dried) powders requiring reconstitution with sterile diluents before use, cerebrolysin is manufactured as a liquid suspension and supplied pre-formulated in sealed ampoules. This significant practical advantage eliminates the preparation steps required by powder products: no need to measure diluent volumes, no mixing time, no risk of incomplete dissolution, and no uncertainty about final concentration. The ready-mixed formulation dramatically simplifies administration, reduces preparation errors, and permits rapid delivery—particularly important in acute stroke where treatment within hours of symptom onset improves outcomes substantially.

Cerebrolysin's liquid formulation consists of enzymatically hydrolyzed porcine brain tissue peptides suspended in saline with trace buffers and stabilizers. The mixture is sterile, pyrogen-free, and tested for bacterial contamination before distribution. The ampoule maintains product sterility through a sealed glass container filled with inert atmosphere (nitrogen), preventing oxidation and bacterial contamination.

Product Storage and Stability

Cerebrolysin ampoules must be stored at 2-8 degrees Celsius (refrigerator temperature), protected from light. Storage at room temperature accelerates peptide degradation through enzymatic hydrolysis and oxidation; product stored at 25°C shows measurable potency decline within days. Light exposure (particularly ultraviolet light) degrades peptide structure; cerebrolysin ampoules are supplied in amber (light-protective) glass or stored in light-protective cardboard packaging. Proper storage at 2-8°C permits shelf life of 24-36 months from manufacturing date; expiration dates printed on each ampoule should be respected—using expired product risks reduced efficacy or, theoretically, adverse effects from degradation products.

Freezing absolutely must be avoided; frozen cerebrolysin thaws incompletely and shows markedly reduced efficacy. The peptide mixture denatures upon freezing with ice crystal formation disrupting molecular structure. Once thawed, frozen-then-thawed cerebrolysin should be discarded. Individuals transporting cerebrolysin should use insulated packaging with ice packs maintaining 2-8°C during transit; extended room-temperature transport is acceptable (24-48 hours) if necessary, but should be minimized. Do not expose cerebrolysin to direct sunlight or heat sources.

Aseptic Handling Technique

Though cerebrolysin requires no mixing, strict aseptic handling prevents contamination during administration preparation. Cerebrolysin ampoules should be stored in refrigerator until 15-30 minutes before use, allowing the product to reach room temperature (injecting cold liquid is uncomfortable and slows absorption). Inspect the ampoule visually for particulates, discoloration, or cloudiness—normal product is clear to slightly turbid and colorless to pale yellow. If the ampoule appears abnormal, discard it. Clean the top of the ampoule with a 70% isopropyl alcohol pad, allowing 30 seconds for complete drying.

Using an aseptic needle (18-20 gauge works well, or 25 gauge for reduced pressure), position the needle at a 45-degree angle to the rubber septum at the ampoule top and puncture smoothly with steady pressure. The needle should penetrate completely through the rubber into the glass ampoule interior. Withdraw the prescribed dose into a sterile syringe—typically 10-30 mL depending on the treatment protocol. After withdrawing the desired volume, smoothly withdraw the needle. Do not touch the needle afterward; replace it with a fresh sterile needle before administration (the original needle that punctured the rubber should never contact the patient). This ensures the injection receives a fresh, non-cored needle.

Withdrawal Techniques and Preventing Coring

Ampoule glass coring (small glass fragments entering the syringe during withdrawal) is a potential contamination risk. Coring occurs when the needle's bevel damages the rubber septum excessively, producing rubber particles mixed with the medication. To minimize coring: (1) Use sharp needles; dull needles increase required pressure and coring risk. (2) Puncture the septum perpendicular (90-degree angle) rather than at shallow angles. (3) Withdraw needle smoothly without twisting. (4) Use 18-20 gauge needles rather than very fine gauges (>27G) which can deflect and core excessively. After withdrawal, allow the syringe to sit briefly (10-30 seconds) permitting any particulates to settle at the syringe base; when administering IV, do not push the final plunger portion that might contain any settled particles, or use a 0.22-micron filter needle that removes particulates before administration.

Dilution for IV Administration

For IV administration, cerebrolysin may be administered undiluted or diluted in normal saline to reduce vascular irritation. IV push (rapid undiluted administration) is faster but carries greater risk of vascular irritation and systemic effects (dizziness, hypertension). IV infusion of diluted cerebrolysin (20 mL cerebrolysin diluted in 100-200 mL normal saline, infused over 15-30 minutes) is gentler and associated with fewer adverse effects. Most clinical protocols use dilution. The dilution ratio is flexible; recommendations range from 1:3 to 1:10 (cerebrolysin:saline). Higher dilution ratios (more saline) produce smoother infusion but require larger-volume infusions; lower dilution ratios concentrate the product but carry more vascular irritation risk. Clinical practice typically uses 1:5 ratio (20 mL cerebrolysin in 100 mL saline).

For IM administration, cerebrolysin is administered undiluted; dilution is not recommended because delayed absorption from diluted product reduces peak concentration and clinical efficacy. Maximum IM volume per injection is approximately 5 mL; larger volumes cause unacceptable injection site pain and inflammatory response.

Pre-Administration Checks and Safety Protocols

Before administering cerebrolysin, verify several elements: (1) Patient identity (confirm you have the correct patient using two identifiers—name and date of birth or medical record number). (2) Product identity (confirm the ampoule is cerebrolysin, not another product). (3) Expiration date (the printed date should be in the future; do not use expired product). (4) Product integrity (visual inspection for discoloration, particulates, or damaged ampoule). (5) Storage history (confirm ampoule has been refrigerated; do not use if storage history is unknown). (6) Route confirmation (confirm IV versus IM based on treatment plan). (7) Dose verification (confirm the ordered dose matches the prepared dose). Documentation should record the cerebrolysin lot number, expiration date, and time of administration for traceability.

Medical staff administering cerebrolysin should verify allergic history (particularly porcine protein allergy) and screen for contraindications before administration. Baseline vital signs should be documented. The patient should remain supervised for at least 30 minutes post-administration for adverse event observation.

Handling Special Situations

Multi-dose ampoules (rarely used): Some institutional purchases include multi-dose vials permitting multiple withdrawals from a single vial. After initial puncture, a rubber septum remains on the vial. After each withdrawal, the vial should be recapped with a sterile needle cover. Multi-dose vials should be stored at 2-8°C and used within 28 days of opening; after 28 days, any remaining product should be discarded due to potential contamination.

Temperature-compromised product: If cerebrolysin has been exposed to room temperature for extended periods (>48 hours) or freezing, the product efficacy is uncertain. Unless storage conditions are documented and clearly appropriate, it is safest to discard temperature-compromised product rather than risk reduced efficacy or theoretical degradation product toxicity.

Partial ampoule use: Cerebrolysin ampoules are single-use and should not be stored after puncture. Unused contents remaining after a treatment session should be discarded. Do not attempt to store the remaining cerebrolysin for later use; contamination and degradation risks outweigh minimal cost savings.

Preparation Workflow Summary

1. Retrieve refrigerated cerebrolysin ampoule; inspect for integrity and expiration date. 2. Allow ampoule to warm to room temperature (15-30 minutes). 3. Visually inspect ampoule contents (should be clear or slightly turbid, colorless to pale yellow). 4. Clean ampoule top with 70% isopropyl alcohol; allow 30 seconds drying. 5. Using sterile needle, puncture ampoule septum perpendicularly. 6. Draw prescribed dose into sterile syringe using smooth withdrawal. 7. Remove the original needle; replace with fresh sterile needle for administration. 8. For IV: dilute in normal saline if desired (1:5 ratio typical). 9. Verify patient identity and confirm dose one final time. 10. Administer via IV infusion over 15-30 minutes or IM injection using standard technique. 11. Document lot number, expiration date, dose, time, and route. 12. Discard ampoule and any unused contents in appropriate medical waste.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Frequently Asked Questions: Cerebrolysin Handling

Do I need bacteriostatic water or normal saline to reconstitute cerebrolysin? No. Cerebrolysin comes pre-mixed and requires no reconstitution. For IV dilution, normal saline is appropriate; bacteriostatic water is not necessary and not recommended for this purpose.

Can cerebrolysin be mixed with other medications? Cerebrolysin should not be mixed in the same IV line with other medications unless specific compatibility has been established. Administer cerebrolysin first, then flush the line with saline, before administering other medications. Y-site incompatibilities may exist with certain drugs; consult compatibility references when uncertain.

How long can cerebrolysin sit after being drawn up in a syringe? Prepared cerebrolysin should be administered within 30 minutes of preparation. Longer standing risks particulate formation or degradation; if preparation must occur >30 minutes before administration, refrigerate the filled syringe.

Is room temperature storage acceptable temporarily? Brief room temperature exposure (<6 hours) is acceptable if necessary. Extended room temperature storage (>24 hours) significantly compromises product quality. Maintain refrigeration whenever possible.

What should I do if the ampoule contents appear cloudy or discolored? Discard the ampoule immediately without administering. Cloudiness or discoloration indicates degradation, contamination, or manufacturing defect. Do not use questionable product.

Can I use cerebrolysin that has been partially used or stored between patients? No. Each ampoule is single-use. Once opened/punctured, any unused contents must be discarded. Do not save partial ampoules for later use.